---
authors:
- Bruehlman, Alyssa
- Salisbury-Afshar, Elizabeth
category: Clinical Review
clinical_significance: High
external_resources:
- title: PubMed Entry
  type: reference
  url: https://pubmed.ncbi.nlm.nih.gov/38804761/
file_path: 2024/05/pharmacotherapy-for-adults-with-alcohol-use-disorder.md
issue: '5'
keywords:
- Alcohol Deterrents
- Alcohol-Related Disorders
- Humans
- Naltrexone
- Adult
- Alcoholism
last_updated: '2025-07-30'
mesh_terms:
- Humans
- Adult
- Alcohol Deterrents
- Alcoholism
- Naltrexone
- Alcohol-Related Disorders
original_format: PubMed
pages: 459-462
patient_population: Adults
peer_reviewed: true
pmid: '38804761'
processed_date: '2025-07-30'
publication_date: '2024-05-01'
pubmed_enriched: true
pubmed_enriched_date: '2025-08-10'
reading_time_minutes: 5
source: American family physician
specialty:
- Family Medicine
status: processed
tags:
- clinical-review
- family-practice
- clinical-medicine
- pubmed-enhanced
title: Pharmacotherapy for Adults With Alcohol Use Disorder.
topics:
- Family Medicine
volume: '109'
publication_types: &id001
- Journal Article
pubmed_content_enriched: true
pubmed_full_data:
  pmid: '38804761'
  title: Pharmacotherapy for Adults With Alcohol Use Disorder.
  authors:
  - last_name: Bruehlman
    fore_name: Alyssa
    initials: A
    affiliation: University of Pennsylvania, Philadelphia, Pennsylvania.
  - last_name: Salisbury-Afshar
    fore_name: Elizabeth
    initials: E
    affiliation: University of Wisconsin-Madison School of Medicine and Public Health,
      Madison, Wisconsin.
  journal_info:
    title: American family physician
    iso_abbreviation: Am Fam Physician
    volume: '109'
    issue: '5'
  publication_info:
    year: '2024'
    month: '05'
    full_date: '2024-05-01'
  article_ids: {}
  mesh_terms:
  - descriptor: Humans
    major_topic: false
  - descriptor: Adult
    major_topic: false
  - descriptor: Alcohol Deterrents
    major_topic: true
    qualifiers:
    - qualifier: therapeutic use
      major_topic: false
  - descriptor: Alcoholism
    major_topic: true
  - descriptor: Naltrexone
    major_topic: false
    qualifiers:
    - qualifier: therapeutic use
      major_topic: false
  - descriptor: Alcohol-Related Disorders
    major_topic: false
    qualifiers:
    - qualifier: drug therapy
      major_topic: false
  publication_types: *id001
related_articles:
- pmid: '38804761'
  title: Pharmacotherapy for Adults With Alcohol Use Disorder.
  authors:
  - name: Bruehlman A
    authtype: Author
    clusterid: ''
  - name: Salisbury-Afshar E
    authtype: Author
    clusterid: ''
  source: Am Fam Physician
  pubdate: 2024 May
- pmid: '23604277'
  title: 'Review: In alcohol use disorders, acamprosate is more effective for inducing
    abstinence while naltrexone is more effective for reducing heavy drinking and
    craving.'
  authors:
  - name: Soyka M
    authtype: Author
    clusterid: ''
  source: Evid Based Ment Health
  pubdate: 2013 Aug
- pmid: '28538998'
  title: More Treatments on Deck for Alcohol Use Disorder.
  authors:
  - name: Lyon J
    authtype: Author
    clusterid: ''
  source: JAMA
  pubdate: 2017 Jun 13
- pmid: '27419333'
  title: Pharmacotherapy for Adults with Alcohol Use Disorder.
  authors:
  - name: Salisbury-Afshar E
    authtype: Author
    clusterid: ''
  source: Am Fam Physician
  pubdate: 2016 Jul 15
- pmid: '17322180'
  title: Alcohol dependence and pharmacologic treatment. Introduction.
  authors:
  - name: McDonough KP
    authtype: Author
    clusterid: ''
  source: Am J Health Syst Pharm
  pubdate: 2007 Mar 1
---

# Pharmacotherapy for Adults With Alcohol Use Disorder.

**Authors:** Bruehlman, Alyssa, Salisbury-Afshar, Elizabeth

**Published in:** American family physician | Vol. 109, No. 5 | 2024-05-01

**Links:** [PubMed](https://pubmed.ncbi.nlm.nih.gov/38804761/)

## Clinical Information

**Population:** Adults | **Clinical Significance:** High

## Topics & Specialties

**Specialties:** Family Medicine

**Topics:** Family Medicine

## MeSH Terms

Humans, Adult, Alcohol Deterrents, Alcoholism, Naltrexone, Alcohol-Related Disorders

## Article Content

*Full article content to be extracted and formatted from source material.*

## Additional Resources

- [PubMed Entry](https://pubmed.ncbi.nlm.nih.gov/38804761/) (reference)

---

*Processed: 2025-07-30* | *PubMed Enhanced: 2025-07-30*
